NamePineda Vergara, Juan Antonio
DepartmentMedicina
Knowledge areaMedicina
Professional categoryInvestigador Honorario
E-mailRequest
         
  • No. publications

    21

  • No. visits

    1512

  • No. downloads

    3550


 

Article
Icon

The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations (GEHEP-012 study)

Martín Sierra, Carmen; José Bravo, María; Sáez, María E.; de Rojas, Itziar; Santos, Marta; Martín Carmona, Jesica; González-Serna Martín, Manuel Alejandro; Pineda Vergara, Juan Antonio; Macías Sánchez, Juan; Real Navarrete, Luis Miguel (Elsevier, 2024)
Background & aims: It has been reported that specific killer-cell immunoglobulin-like receptors (KIRs) and HLA genotype ...
Article
Icon

Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver

Cabezas, Joaquin; Crespo, Javier; Aguilera, Antonio; Albillos, Agustin; Buti, Maria; Calleja, Jose Luis; Pineda Vergara, Juan Antonio; Romero Gómez, Manuel; Turnes, Juan (Aran Ediciones S.A., 2023)
Back in January 2022, a The Lancet-European Association for the Study of the Liver (EASL) Commission on the impact of ...
Article
Icon

Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis

Macías Sánchez, Juan; Parra Membrives, Pablo; Sosa Moreno, Francisco; Rincón, Pilar; Martínez Baena, Darío; Fernández Fuertes, Marta; Lorente Herce, José Manuel; Martínez, Rafael C.; Jiménez Riera, Águeda Granada; Corma Gómez, Anaïs; González-Serna Martín, Manuel Alejandro; Pineda Vergara, Juan Antonio; Real, Luis Miguel (Nature Research, 2022)
The diagnosis of non-alcoholic steatohepatitis (NASH) requires liver biopsy. Patients with NASH are at risk of progression ...
Article
IconIcon

High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use

González-Serna Martín, Manuel Alejandro; Macías Sánchez, Juan; Corma Gómez, Anaïs; Tellez, Francisco; Cucurull, Josep; Real Navarrete, Luis Miguel; Granados, Rafael; Rivero Juárez, Antonio; Hernández Quero, José; Merino, Dolores; Palacios, Rosario; Ríos-Villegas, María José; Collado, Antonio; Pineda Vergara, Juan Antonio (Elsevier, 2022)
Objectives Real world data on glecaprevir/pibrentasvir (G/P) among active drug users are scarce. We evaluated the sustained ...
Article
Icon

Orthohepevirus C infection as an emerging cause of acute hepatitis in Spain: First report in Europe

Rivero-Juárez, Antonio; Frías, Mario; Pérez, Ana Belén; Pineda Vergara, Juan Antonio; Reina, Gabriel; Fuentes-López, Ana; Freyre Carrillo, Carolina; Ramírez-Arellano, Encarnación; Alados, Juan Carlos; Rivero, Antonio (Elsevier, 2022)
Background & Aim Hepatitis E virus (HEV) was considered the only member of the Hepeviridae family with zoonotic potential. ...
Article
Icon

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Bellenguez, Céline; Küçükali, Fahri; Jansen, Iris E.; Kleineidam, Luca; Moreno-Grau, Sonia; Sonia; Amin; Macías Sánchez, Juan; Pineda Vergara, Juan Antonio; Lambert, Jean-Charles (Nature Publishing Group, 2022)
Characterization of the genetic landscape of Alzheimer’s disease (AD) and related dementias (ADD) provides a unique ...
Article
Icon

Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV

Martínez-Sanz, Javier; Ron, Raquel; Moreno, Elena; Sánchez-Conde, Matilde; Muriel, Alfonso; López Cortés, Luis Fernando; Pineda Vergara, Juan Antonio; Serrano-Villar, Sergio (FRONTIERS MEDIA SA, 2022)
The initiation of antiretroviral treatment based on a 2-drug regimen (2DR) with dolutegravir plus lamivudine has demonstrated ...
Article
Icon

CD46 Genetic Variability and HIV-1 Infection Susceptibility

Serrano Rísquez, Carmen; Omar, Mohamed; Gómez Vidal, María Amparo; Real, Luis Miguel; Pineda Vergara, Juan Antonio; Rivero, Antonio; Caruz, Antonio (MDPI, 2021)
CD46 is the main receptor for complement protein C3 and plays an important role in adaptive immune responses. CD46 genetic ...
Article
Icon

Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01

Weiner, January; Suwalski, Phillip; Holtgrewe, Manuel; Rakitko, Alexander; Macías Sánchez, Juan; Pineda Vergara, Juan Antonio; Heidecker, Bettina (2021)
Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been increasing urgency to ...
Article
Icon

A genome-wide association study on liver stiffness changes during hepatitis c virus infection cure

Corma-Gómez, A; Macías Sánchez, Juan; Rivero, A.; Rivero-Juárez, A.; Santos, I. de los; Reus-Bañuls, S.; González-Serna Martín, Manuel Alejandro; Pineda Vergara, Juan Antonio (MDPI, 2021)
Liver stiffness (LS) at sustained virological response (SVR) after direct-acting antivirals (DAA)-based therapy is a ...
Article
Icon

Limited value of single sampling for IgM antibody determination as a diagnostic approach for acute hepatitis E virus infection

Rivero-Juárez, Antonio; López-López, Pedro; Pineda Vergara, Juan Antonio; Alados, Juan Carlos; Fuentes-López, Ana; Ramírez-Arellano, Encarnación; Freyre Carrillo, Carolina; Rivero, Antonio (Amer Soc Microbiology, 2021)
ABSTRACT The objective was to evaluate the accuracy of a single determination of IgM antibodies for hepatitis E virus (HEV) ...
PhD Thesis
Icon

Factores predictores de eventos clínicos tras la respuesta viral sostenida en pacientes con infección crónica por el virus de la hepatitis C y fibrosis hepática avanzada

Corma Gómez, Anaïs; Pineda Vergara, Juan Antonio; Real Navarrete, Luis Miguel (2021)
A pesar de las altas tasas de curación de la infección por el virus de la hepatitis C (VHC) a partir de la reciente ...
Article
Icon

Genomic characterization of host factors related to SARS-CoV-2 infection in people with dementia and control populations: the GR@ACE/DEGESCO study

Rojas, Itziar de; Hernández, Isabel; Montrreal, Laura; Quintela, Inés; Calero, Miguel; Royo, José Luis; Macías Sánchez, Juan; Pineda Vergara, Juan Antonio; Mir Rivera, Pablo; Ruiz, Agustín (MDPI, 2021)
Emerging studies have suggested several chromosomal regions as potential host genetic factors involved in the susceptibility ...
Article
Icon

Long runs of homozygosity are associated with Alzheimer’s disease

Moreno-Grau, Sonia; Fernández, María Victoria; de Rojas, Itziar; García-González, Pablo; Hernández, Isabel; Farias, Fabiana; Pineda Vergara, Juan Antonio; Macías Sánchez, Juan; Mir Rivera, Pablo; Periñán Tocino, María Teresa (Nature Publishing Group, 2021)
Long runs of homozygosity (ROH) are contiguous stretches of homozygous genotypes, which are a footprint of inbreeding and ...
Article
Icon

Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy

Macías Sánchez, Juan; González Moreno, Paz; Sánchez García, Esther; Morillo Verdugo, Ramón Alejandro; Pérez Venegas, José J.; Pinilla, Ana; Macho, M. Mar; Martínez, M. Victoria; González-Serna Martín, Manuel Alejandro; Corma, Anaïs; Real, Luis M.; Pineda Vergara, Juan Antonio (Public Library of Science, 2021)
Background Hydroxychloroquine is not efficacious as post-exposure prophylaxis against coronavirus disease 2019 (COVID-19). ...
Article
Icon

Drug–drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain

Cantudo-Cuenca, M. D.; Gutiérrez-Pizarraya, Antonio; Pinilla-Fernández, Ana; Contreras-Macías, Enrique; Fernández‑Fuertes, M.; Pineda Vergara, Juan Antonio; Macías Sánchez, Juan; Morillo Verdugo, Ramón Alejandro (NATURE PUBLISHING GROUP, 2021)
Primary aim was to assess prevalence and severity of potential and real drug–drug interactions (DDIs) among therapies for ...
Article
Icon

Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)

Crespo, Javier; Albillos, Agustín; Calleja, Jose Luis; García Samaniego, Javier; Hernández Guerra, Manuel; Serrano, Trinidad; Pineda Vergara, Juan Antonio; Romero Gómez, Manuel; Sánchez Antolín, Gloria (Aran Ediciones S.A., 2019)
The Spanish Association for the Study of the Liver (AEEH) is convinced that the elimination of hepatitis C virus (HCV) ...
Article
Icon

No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014

Neukam, Karin; Viciana Fernández, Pompeyo; Ojeda-Burgos, Guillermo; Delgado-Fernández, Marcial; Ríos, María J; Macías Sánchez, Juan; Pineda Vergara, Juan Antonio (BioMed Central, 2016)
Background: Acute hepatitis C virus (HCV) infection (AHCVI) outbreaks have been described recently within defined areas ...
PhD Thesis
Icon

Historia natural de la cirrosis hepática compensada diagnosticada por elastografía hepática transitoria en pacientes coinfectados por el virus de la inmunodeficiencia humana y el virus de la hepatitis C

Merchante Gutiérrez, Nicolás; Pineda Vergara, Juan Antonio (2015)
Pacientes y métodos Estudio multicéntrico prospectivo de cohortes llevado a cabo en 7 hospitales andaluces. A partir de ...
Article
Icon

Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients

Rivero-Juárez, Antonio; López Cortés, Luis Fernando; Camacho, Ángela; Torres Cornejo, Almudena; Pineda Vergara, Juan Antonio; Márquez-Solero, Manuel; Rivero, Antonio (Public Library of Science, 2012)
Background: The aim of the study was to analyze the different impact of standard and low-dose Peg-IFN-a2a/RBV therapies on ...
PhD Thesis